Myeloma Nurse Consultant, Clinical Associate Professor
Royal Prince Alfred Hospital, The University of Sydney, Australia
Tracy King PhD, MN, RN, Myeloma Clinical Nurse Consultant, Royal Prince Alfred Hospital; Clinical Research Fellow & Clinical Lecturer; Cancer Nursing Research Unit, Sydney University, Sydney Australia.
Tracy King is a Myeloma Clinical Nurse Consultant within the Institute of Haematology Royal Prince Alfred Hospital. She also holds an affiliate position as Clinical Research Fellow and Lecturer at the Cancer Nursing Research Unit, Sydney University. With over 30 years’ experience in the field of Haematology / BMT, Tracy developed a specialist interest in myeloma 20yrs ago working with the International Myeloma Foundation (IMF), now Myeloma UK. Since coming to Australia Tracy has been an active member of a range of national and international professional working groups including those of the Cancer Institute NSW; Myeloma and Related Disease Registry (MRDR), is Chair of the HSANZ Myeloma Special Practice Network (M-SPN) and Past President and co-founder of the HSANZ Nurses Group. Tracy is an invited member of the IMF Nurse Leadership Board (NLB) and leads the nurse’s program development and delivery during the International Myeloma Workshop (IMW). She was awarded the Outstanding Research Achievement Nursing & Midwifery Award, 2019 by Sydney Local Health Network (SLHD) for her leadership and research in better understanding the experiences of those affected by myeloma and the role of patient reported outcome measures (PROM). Tracy was recently awarded her PhD with Sydney University for the development and evaluation of a PROM to measure the impact of steroids associated with therapy for myeloma.